Tech Company Financing Transactions

Enobia Pharma Funding Round

Enobia Pharma, based in Cambridge, secured $50 million from Desjardins Venture Capital, OrbiMed and private investors.

Transaction Overview

Company Name
Announced On
8/10/2009
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Series C
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
55 Cambridge Parkway 800
Cambridge, MA 02142
USA
Email Address
Not Recorded
Overview
Enobia Pharma is a developer of enzyme replacement therapies for the treatment of serious bone diseases.
Profile
Enobia Pharma LinkedIn Company Profile
Social Media
Enobia Pharma Company Twitter Account
Company News
Enobia Pharma News
Facebook
Enobia Pharma on Facebook
YouTube
Enobia Pharma on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Robert Heft
  Robert Heft LinkedIn Profile  Robert Heft Twitter Account  Robert Heft News  Robert Heft on Facebook
Chief Financial Officer
Jeff Mack
  Jeff Mack LinkedIn Profile  Jeff Mack Twitter Account  Jeff Mack News  Jeff Mack on Facebook
Chief Medical Officer
Hal Landy
  Hal Landy LinkedIn Profile  Hal Landy Twitter Account  Hal Landy News  Hal Landy on Facebook
Chief Scientific Officer
Philippe Crine
  Philippe Crine LinkedIn Profile  Philippe Crine Twitter Account  Philippe Crine News  Philippe Crine on Facebook
VP - Finance
Luc Cournoyer
  Luc Cournoyer LinkedIn Profile  Luc Cournoyer Twitter Account  Luc Cournoyer News  Luc Cournoyer on Facebook
VP - General Counsel
Eric Trachtenberg
  Eric Trachtenberg LinkedIn Profile  Eric Trachtenberg Twitter Account  Eric Trachtenberg News  Eric Trachtenberg on Facebook
VP - Manufacturing
Bernhard Eggimann
  Bernhard Eggimann LinkedIn Profile  Bernhard Eggimann Twitter Account  Bernhard Eggimann News  Bernhard Eggimann on Facebook
VP - Regulatory Affairs
Deborah Ramsdell
  Deborah Ramsdell LinkedIn Profile  Deborah Ramsdell Twitter Account  Deborah Ramsdell News  Deborah Ramsdell on Facebook


 

 

Browse more venture capital transactions:

Prev: 8/9/2009: Symwave venture capital transaction
Next: 8/10/2009: Amalfi Semiconductor venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on funding rounds that are announced publicly. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary